191 related articles for article (PubMed ID: 16909008)
1. Developing novel immunogens for an effective, safe Alzheimer's disease vaccine.
Maier M; Seabrook TJ; Lemere CA
Neurodegener Dis; 2005; 2(5):267-72. PubMed ID: 16909008
[TBL] [Abstract][Full Text] [Related]
2. Short amyloid-β immunogens with spacer-enhanced immunogenicity without junctional epitopes for Alzheimer's disease immunotherapy.
Guan X; Zou J; Gu H; Yao Z
Neuroreport; 2012 Oct; 23(15):879-84. PubMed ID: 22922658
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of A beta plaque clearance following passive A beta immunization.
Morgan D
Neurodegener Dis; 2005; 2(5):261-6. PubMed ID: 16909007
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta-HSP60 peptide conjugate vaccine treats a mouse model of Alzheimer's disease.
Nemirovsky A; Fisher Y; Baron R; Cohen IR; Monsonego A
Vaccine; 2011 May; 29(23):4043-50. PubMed ID: 21473952
[TBL] [Abstract][Full Text] [Related]
5. Novel Abeta immunogens: is shorter better?
Lemere CA; Maier M; Peng Y; Jiang L; Seabrook TJ
Curr Alzheimer Res; 2007 Sep; 4(4):427-36. PubMed ID: 17908047
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a new DNA vaccine for Alzheimer's disease elicited Th2 immune response in BALB/c mice by in vivo electroporation.
Xing X; Sha S; Li Y; Zong L; Jiang T; Cao Y
J Neurol Sci; 2012 Feb; 313(1-2):17-21. PubMed ID: 22029939
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
8. Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.
Lemere CA
Prog Brain Res; 2009; 175():83-93. PubMed ID: 19660650
[TBL] [Abstract][Full Text] [Related]
9. A beta immunotherapy: Lessons learned for potential treatment of Alzheimer's disease.
Schenk DB; Seubert P; Grundman M; Black R
Neurodegener Dis; 2005; 2(5):255-60. PubMed ID: 16909006
[TBL] [Abstract][Full Text] [Related]
10. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
[TBL] [Abstract][Full Text] [Related]
11. [Vaccination therapy for Alzheimer's disease].
Tabira T
Brain Nerve; 2007 Apr; 59(4):375-82. PubMed ID: 17447524
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta vaccination for Alzheimer's dementia.
McGeer PL
Lancet; 2008 Oct; 372(9647):1381; author reply 1381-2. PubMed ID: 18940458
[No Abstract] [Full Text] [Related]
13. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
Asami-Odaka A; Obayashi-Adachi Y; Matsumoto Y; Takahashi H; Fukumoto H; Horiguchi T; Suzuki N; Shoji M
Neurodegener Dis; 2005; 2(1):36-43. PubMed ID: 16909001
[TBL] [Abstract][Full Text] [Related]
14. Intramuscular delivery of a single chain antibody gene prevents brain Aβ deposition and cognitive impairment in a mouse model of Alzheimer's disease.
Wang YJ; Gao CY; Yang M; Liu XH; Sun Y; Pollard A; Dong XY; Wu XB; Zhong JH; Zhou HD; Zhou XF
Brain Behav Immun; 2010 Nov; 24(8):1281-93. PubMed ID: 20595065
[TBL] [Abstract][Full Text] [Related]
15. Abeta DNA vaccination for Alzheimer's disease: focus on disease prevention.
Cribbs DH
CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):207-16. PubMed ID: 20205639
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans.
Lemere CA; Maier M; Jiang L; Peng Y; Seabrook TJ
Rejuvenation Res; 2006; 9(1):77-84. PubMed ID: 16608400
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Alzheimer's disease.
Gelinas DS; DaSilva K; Fenili D; St George-Hyslop P; McLaurin J
Proc Natl Acad Sci U S A; 2004 Oct; 101 Suppl 2(Suppl 2):14657-62. PubMed ID: 15297619
[TBL] [Abstract][Full Text] [Related]
18. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
19. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
20. Vaccine approach for Alzheimer's disease revisited.
Frantz S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368652
[No Abstract] [Full Text] [Related]
[Next] [New Search]